Viberzi (Eluxadoline Tablet) 75mg

Viberzi (Eluxadoline 75mg) is an oral tablet for adults managing symptoms of irritable bowel syndrome with diarrhea. This prescription medication helps reduce abdominal pain and diarrhea episodes. Store at room temperature away from moisture. Always follow healthcare provider guidance.

Strength

75mg

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

Allergan ,USA ,INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Viberzi (Eluxadoline) is prescribed to relieve symptoms of irritable bowel syndrome with diarrhea in adults. It works by acting on receptors in the gut to slow intestinal contractions. People often ask, what is Eluxadoline used for, and this medication is specifically indicated for IBS-D symptom control.

Side Effects

Viberzi may help reduce urgent bowel movements and abdominal discomfort associated with IBS-D. Some users notice fewer episodes of diarrhea after starting treatment. Individual responses vary, and effects should be discussed with a healthcare professional.

Precautions & Warnings

Keep Viberzi in a cool, dry place away from children and pets. Do not use if the packaging is damaged or the tablets appear altered. Inform your doctor about any history of liver or pancreas issues before starting this medication.

Avoid Interactions

Certain medications, including strong CYP inhibitors or alcohol, may interact with Viberzi. Avoid grapefruit products while taking this drug. Always review your full medication list with your healthcare provider to check for possible interactions.

Frequently Asked Questions

Viberzi can be taken with or without food; consistency in timing may help maintain steady effects.

Some users report symptom improvement within a few days, but full benefits may take up to a week or longer.

Take the missed dose as soon as you remember, unless it’s nearly time for the next dose; skip the missed dose if it’s close to the next scheduled time.

Constipation is a possible side effect; staying hydrated and discussing diet can help manage this.

Long-term use should be evaluated by a healthcare provider to assess ongoing benefit and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.